Carlsmed, Inc.

Carlsmed, Inc. is a commercial-stage medical technology company headquartered in Carlsbad, California, pioneering AI-enabled personalized spine surgery solutions. Its mission is to improve patient outcomes and decrease healthcare costs associated with spine surgery.

The company's core offering is the aprevo® Technology Platform, which integrates AI-enabled software solutions, custom-designed 3D-printed interbody implants, and single-use surgical instruments. This platform is utilized for both lumbar and cervical spine fusion procedures, providing personalized surgical plans and devices tailored to each patient's unique anatomy and pathology.

Carlsmed became a publicly traded company on July 23, 2025, listing on Nasdaq under the ticker symbol "CARL." Mike Cordonnier serves as the Co-Founder, President, and Chief Executive Officer. In December 2025, the company commercially launched its aprevo® Technology Platform for cervical fusion surgeries, following its successful application in lumbar procedures. More recently, in February 2026, Carlsmed announced the first personalized cervical plating procedure using its corra™ Cervical Plating System. The company aims to establish its personalized solutions as the standard of care in spine fusion surgery, competing with established medical device manufacturers.